Strategies Involved in Developing an Effective Vaccine for EBV-Associated Diseases
- 1 January 1996
- book chapter
- Published by Elsevier
- Vol. 69, 213-245
- https://doi.org/10.1016/s0065-230x(08)60864-7
Abstract
No abstract availableThis publication has 178 references indexed in Scilit:
- Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is non-immunogenic in a murine model system, in contrast to a B cell-derived homologueEuropean Journal Of Cancer, 1994
- Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T-cell help in CD8+ T-cell responsesCurrent Biology, 1994
- The Nature of Reed-Sternberg Cells: Phenotype, Genotype, and Other PropertiesCritical Reviews™ in Oncogenesis, 1994
- The Pathogenesis of Burkitt's LymphomaPublished by Elsevier ,1990
- Replication of Epstein–Barr Virus within the Epithelial Cells of Oral Hairy Leukoplakia, an AIDS-Associated LesionNew England Journal of Medicine, 1985
- Epstein–Barr Virus Replication in Oropharyngeal Epithelial CellsNew England Journal of Medicine, 1984
- A comparison of epstein‐barr virus‐specific T‐cell immunity in malaria‐endemic and ‐nonendemic regions of Papua New GuineaInternational Journal of Cancer, 1983
- Congenital Cytomegalovirus InfectionNew England Journal of Medicine, 1982
- VARIATIONS AMONG ISOLATES OF EPSTEIN‐BARR VIRUS*Annals of the New York Academy of Sciences, 1980
- Cytotoxicity of circulating leukocytes in cytomegalovirus mononucleosisClinical Immunology and Immunopathology, 1977